VKH
BOLD

Virtu KCG Holdings’s Audentes Therapeutics, Inc BOLD Stock Holding History

Virtu KCG Holdings’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$257K Buy
+13,453
New +$215K 0.01% 1871

Other funds holding BOLD

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Virtu KCG Holdings's BOLD Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Audentes Therapeutics, Inc (BOLD) in Q2 2017: 13,453 shares worth $257K. The stake represents 0.01% of the portfolio and ranks #1871 among its holdings.

70 funds tracked by Wall St. Rank hold BOLD as of Q2 2017.

  • Virtu KCG Holdings held 13,453 shares of Audentes Therapeutics, Inc worth $257K as of Q2 2017.
  • Audentes Therapeutics, Inc was a new Virtu KCG Holdings position in Q2 2017.
  • Audentes Therapeutics, Inc made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1871 holding.
  • 70 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.